The Searle Company Limited (PSX:SEARL)

Market Cap	62.46B
Revenue (ttm)	28.60B
Net Income (ttm)	-1.40B
Shares Out	588.22M
EPS (ttm)	-2.38
PE Ratio	79.97
Forward PE	18.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,550,044
Average Volume	8,005,275
Open	106.50
Previous Close	104.94
Day's Range	105.10 - 107.75
52-Week Range	52.39 - 112.45
Beta	0.44
RSI	57.89
Earnings Date	Oct 3, 2025

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 3,799
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.